MCRB
Seres Therapeutics Inc.
Company Overview
| Mkt Cap | $165.55M | Price | $16.10 |
| Volume | 45.01K | Change | +2.03% |
| P/E Ratio | 1217.3 | Open | $15.99 |
| Revenue | -- | Prev Close | $15.78 |
| Net Income | $136.0K | 52W Range | $6.53 - $24.67 |
| Div Yield | N/A | Target | $16.00 |
| Overall | 43 | Value | 75 |
| Quality | 34 | Technical | 20 |
No chart data available
Stock Overview
Updated DailySeres Therapeutics Inc. (MCRB) is a leading Healthcare company in the Biotechnology industry, currently trading at $16.10 with a market capitalization of $165.55 million. The stock is trading in the middle of its 52-week range, demonstrating concerning quality fundamentals with a MarketXLS quality score of 34.
Today's trading session shows MCRB with a volume of 45K shares. The stock opened up 1.33% from yesterday's close of $15.78. Current analyst estimates project earnings of $-0.99 per share for this year, with next year targeting $-10.66.
MCRB demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including XNCR, BLCM, XOMA, AGIO.
Key investment considerations for MCRB include below-average investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -0.6%. The stock shows reasonable valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 07:10 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | MCRB | $16.10 | +2.0% | 45.01K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |